Skip to main content
Clinical Trials/ISRCTN39634732
ISRCTN39634732
Completed
Phase 3

A randomised controlled trial of hyperbaric oxygen to prevent osteoradionecrosis of the irradiated mandible

niversity of Liverpool (UK)0 sites200 target enrollmentJune 13, 2008

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
niversity of Liverpool (UK)
Enrollment
200
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 13, 2008
End Date
TBD
Last Updated
9 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
niversity of Liverpool (UK)

Eligibility Criteria

Inclusion Criteria

  • 1\. Both males and females, age \>18 years
  • 2\. Prior history of external beam radiotherapy (dose \>50 Gy) to mandible or prior history of brachytherapy with equivalent radiation dose as above
  • 3\. No evidence of cancer recurrence
  • 4\. Condition requiring surgery to mandible (commonest examples but not limited to: dental extraction, implant placement, surgical tooth, cyst or osteosynthesis plate removal)
  • 5\. Patient has read and understood information leaflet and is willing to be randomised
  • 6\. Patient competent to consent and psychologically/ physically fit for HBO

Exclusion Criteria

  • 1\. Known contraindications to HBO:
  • 1\.1\. Lung disease: Severe chronic obstructive airways disease; bullous lung disease, acute or chronic pulmonary infection; uncontrolled asthma, untreated pneumothorax
  • 12\. Middle ear disease (such as previous middle ear operations, eustachian tube dysfunction or recurrent attacks of vertigo) that proves refractory to simple interventions such as grommet insertion
  • 2\. Prior hyperbaric oxygen therapy
  • 3\. Prior diagnosis of osteoradionecrosis of the mandible
  • 4\. Previous surgery for osteoradionecrosis
  • 5\. Any history of systemic bisphosphonate therapy, pentoxyphylline or tocopherol
  • 6\. Pregnancy

Outcomes

Primary Outcomes

Not specified

Similar Trials